2022 Capital Markets Day presentation

ROVI updates its strategy in a meeting with shareholders, investors and analysts


TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION

(COMISIÓN NACIONAL DEL MERCADO DE VALORES)

Madrid, 23 November 2022

In compliance with the reporting requirements provided for in article 227 of the consolidated text of the Securities Market Act, ROVI sends and publishes the attached presentation regarding the update of the company strategy, a presentation that will be distributed today and which can be accessed through the website of the company. Likewise, ROVI will hold an in-person and virtual meeting today with analysts and investors to present said presentation.

 

Mr. Juan López-Belmonte Encina

Chairman and Chief Executive Officer

Laboratorios Farmacéuticos ROVI, S.A.

 

Average: 3 (2 votes)
 
Related
Madrid, 12 March 2024 Laboratorios Farmacéuticos ROVI, S.A. (hereinafter, ROVI), informs of the agreement that has been concluded with...
3 min
12/03/2024
ROVI ACHIEVED OPERATING REVENUE GROWTH OF 1% IN THE FIRST POST-PANDEMIC YEAR Operating revenue increased 1% to 829.5 million euros in...
4 min
27/02/2024
ROVI REPORTS OPERATING REVENUE GROWTH OF 3% FOR THE FIRST NINE MONTHS OF THE FIRST POST-PANDEMIC YEAR Operating revenue increased 3%...
5 min
08/11/2023